NCT07601282

Brief Summary

This observational study aims to develop a predictive model for the occurrence of new-onset stress urinary incontinence (SUI) after pelvic organ prolapse (POP) repair surgery in women. The primary questions it seeks to answer are: Which risk factors and anatomical characteristics predispose women to new-onset stress urinary incontinence following pelvic organ prolapse repair surgery? Female POP patients without any preoperative symptoms of urinary incontinence will receive telephone follow-ups at 3, 6, and 12 months after undergoing standard surgical treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
382

participants targeted

Target at P75+ for all trials

Timeline
7mo left

Started Dec 2024

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Dec 2024Dec 2026

Study Start

First participant enrolled

December 1, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 18, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 16, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

May 22, 2026

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

May 22, 2026

Status Verified

May 1, 2026

Enrollment Period

1 year

First QC Date

May 16, 2026

Last Update Submit

May 16, 2026

Conditions

Keywords

Case-Control Study

Outcome Measures

Primary Outcomes (1)

  • Pelvic floor ultrasound

    From enrollment to 3 days before surgery

Secondary Outcomes (2)

  • Pelvic Floor Distress Inventory-20 (PFDI-20)

    3 months, 6 months and 12 months after the surgery

  • International Consultation on Incontinence Questionnaire Short Form (ICI-Q-SF)

    3 months, 6 months and 12 months after the surgery

Interventions

Telephone follow-upDIAGNOSTIC_TEST

Participants will be required to complete the PFDI-20 and ICI-Q-SF questionnaires verbally during telephone follow-ups. If postoperative de novo SUI is highly suspected, participants will be advised to attend an outpatient clinic for further evaluation, including a pelvic floor ultrasound examination.

Eligibility Criteria

Age20 Years - 90 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who visited the outpatient clinic of Shanghai General Hospital for pelvic organ prolapse.

You may qualify if:

  • Patients with pelvic organ prolapse quantification (POP-Q) stage II or higher;
  • Patients who require surgical treatment for pelvic organ prolapse;
  • Patients with no evidence of urinary incontinence before surgery.

You may not qualify if:

  • Patients confirmed to have urinary incontinence before surgery;
  • Patients with urinary or reproductive system infections;
  • Patients with a history of prior surgery for urinary incontinence;
  • Patients who have undergone previous mesh repair surgery for pelvic organ prolapse;
  • Patients with a history of psychiatric disorders, hearing impairment, or communication difficulties;
  • Patients receiving hormone replacement therapy;
  • Patients with neurodegenerative diseases such as stroke or multiple sclerosis, or neurological conditions such as spinal cord injury.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai General Hospital

Shanghai, Shanghai Municipality, 200080, China

RECRUITING

MeSH Terms

Conditions

Pelvic Organ ProlapseUrinary Incontinence, Stress

Condition Hierarchy (Ancestors)

ProlapsePathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsUrinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and Symptoms

Central Study Contacts

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
associate chief physician

Study Record Dates

First Submitted

May 16, 2026

First Posted

May 22, 2026

Study Start

December 1, 2024

Primary Completion

December 18, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

May 22, 2026

Record last verified: 2026-05

Data Sharing

IPD Sharing
Will share

all IPD collected throughout the trial

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Raw data will be publicly available from December 31, 2028, valid for 3 years
Access Criteria
After obtaining permission from the project principal investigator via email, access to the IPD public website login will be granted.
More information

Locations